The Mechanism of Immunomodulatory Effects of β-1,3-Glucan Found in Euglena

Euglena contains Paramylon as an intracellular carbohydrate storage substance, and Paramylon has a β-1,3-glucan structure. β-glucans are widely distributed polysaccharides found in nature, including in fungi, bacteria, and plants. They are known to exhibit various physiological activities in the bodies of animals, including humans, and have been reported to have multiple effects, especially related to immune regulation. The effects associated with immune enhancement by β-glucans are believed to be induced through humoral immunity, enhancing resistance against pathogens. When β-glucans are ingested orally, they are thought to influence the mucosal immune system o

Euglena Co., Ltd. have established the Tohoku University Hospital Euglena Immunofunction Research Center.

Euglena Co., Ltd., in an effort to expand its research domain within the medical field, has opened the “Tohoku University Hospital Euglena Immunofunction Research Center” in collaboration with Tohoku University, with a focus on joint research. Building upon previous collaborative efforts with Tohoku University, which primarily involved functional research on the microalgae Euglena, we are now extending our research into the medical field. Through this partnership with a university hospital, we aim to actively engage in research and development activities in the medical field. ■Background Currently, there is a global increase in the dema

Euglena Co., Ltd. have established the Tohoku University Hospital Euglena Immunofunction Research Center.

Euglena Co., Ltd., in an effort to expand its research domain within the medical field, has opened the “Tohoku University Hospital Euglena Immunofunction Research Center” in collaboration with Tohoku University, with a focus on joint research. Building upon previous collaborative efforts with Tohoku University, which primarily involved functional research on the microalgae Euglena, we are now extending our research into the medical field. Through this partnership with a university hospital, we aim to actively engage in research and development activities in the medical field. ■Background Currently, there is a global increase in the dema